peptide IL-6 antagonist (Protagonist)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug Namepeptide IL-6 antagonist (Protagonist)
Drug Alias Namepeptide IL-6 antagonist (Protagonist)
ClassificationBiologics > Protein drugs > Recombinant polypeptide
Mechanisms of ActionIL-6 receptor antagonists
TargetsIL-6 receptor
Therapy Area/IndicationsPsoriasisCrohn DiseaseColitis, Ulcerative +[7] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesProtagonist Therapeutics Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesProtagonist Therapeutics IncIronwood Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsPsoriasisCrohn DiseaseColitis, Ulcerative +[7] 

Other Information

ATC CodeN/A
Related LinksN/A